{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:08:38Z","timestamp":1770066518226,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Sanofi Taiwan Co., Ltd"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.pcd.2014.05.005","type":"journal-article","created":{"date-parts":[[2014,9,27]],"date-time":"2014-09-27T17:20:12Z","timestamp":1411838412000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-7539","authenticated-orcid":false,"given":"Shi-Dou","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Tzer","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Te","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chieh","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Hsiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neng-Chun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Ren","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chia","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2014.05.005_bib0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1016\/j.pcd.2014.05.005_bib0010","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes \u2013 2013","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2337\/dc11-1405","article-title":"Racial\/ethnic- and education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetes","volume":"35","author":"Chatterji","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0020","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pcd.2014.05.005_bib0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jdiacomp.2011.03.005","article-title":"Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review","volume":"25","author":"Giugliano","year":"2011","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.pcd.2014.05.005_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2010.08.006","article-title":"Treatment regimens with insulin analogues and hemoglobin A1c target of <7% in type 2 diabetes: a systematic review","volume":"92","author":"Giugliano","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.pcd.2014.05.005_bib0035","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.diabres.2008.09.006","article-title":"Use of anti-diabetic drugs and glycemic control in type 2 diabetes \u2013 the Hong Kong Diabetes Registry","volume":"82","author":"Tong","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.pcd.2014.05.005_bib0040","first-page":"262","article-title":"Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry","volume":"11","author":"Karter","year":"2005","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.diabres.2007.10.029","article-title":"Controlling the ABCs of diabetes in clinical practice: a community-based endocrinology practice experience","volume":"80","author":"Varma","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.pcd.2014.05.005_bib0050","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1463-1326.2010.01239.x","article-title":"Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes","volume":"12","author":"Owen","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2014.05.005_bib0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/diacare.23.3.273","article-title":"Predictors of glycemic control in insulin-using adults with type 2 diabetes","volume":"23","author":"Nichols","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1742-1241.2010.02619.x","article-title":"Relationship of baseline HbA1c, HbA1c change and HbA1c target of <7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"65","author":"Giugliano","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.pcd.2014.05.005_bib0065","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1463-1326.2011.01412.x","article-title":"An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycemic control and hypoglycemia","volume":"13","author":"Fonseca","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2014.05.005_bib0070","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(08)60736-9","article-title":"Intensive insulin therapy in newly diagnosed type 2 diabetes","volume":"371","author":"Retnakaran","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2014.05.005_bib0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1210\/jc.2008-1824","article-title":"Clinical review 2: the \u201cmetabolic memory\u201d: is more than just tight glucose control necessary to prevent diabetic complications","volume":"94","author":"Ceriello","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pcd.2014.05.005_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1262-3636(07)70275-6","article-title":"Insulin initiation in type 2 diabetic patients admitted in hospital in France and follow-up at 1 year","volume":"32","author":"Raccah","year":"2006","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.pcd.2014.05.005_bib0090","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1185\/03007990902739669","article-title":"Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study","volume":"25","author":"Jones","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.pcd.2014.05.005_bib0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/02813430310004164","article-title":"Factors affecting the efficacy of starting insulin treatment in Type 2 diabetic patients. A retrospective evaluation","volume":"21","author":"V\u00e4h\u00e4talo","year":"2003","journal-title":"Scand. J. Prim. Health Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00115677-200109060-00005","article-title":"Insulin therapy in patients with type 2 diabetes mellitus. Shared care versus secondary outpatient care in The Netherlands","volume":"9","author":"Hutubessy","year":"2001","journal-title":"Dis. Manage. Health Outcomes"},{"key":"10.1016\/j.pcd.2014.05.005_bib0105","first-page":"598","article-title":"Glycemic response to newly initiated diabetes therapies","volume":"13","author":"Karter","year":"2007","journal-title":"Am. J. Manag. Care"},{"issue":"Suppl. 3","key":"10.1016\/j.pcd.2014.05.005_bib0110","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.ijo.0802173","article-title":"When oral agents fail: practical barriers to starting insulin","volume":"26","author":"Korytkowski","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.pcd.2014.05.005_bib0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/diacare.20.3.292","article-title":"NIDDM patients\u2019 fears and hopes about insulin therapy: the basis of patient reluctance","volume":"20","author":"Hunt","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/dc10-1701","article-title":"The DURAbility of Basal versus Lispro mix 75\/25 insulin Efficacy (DURABLE) Trial: comparing the durability of lispro mix 75\/25 and glargine","volume":"34","author":"Buse","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-2006-949655","article-title":"Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride","volume":"114","author":"Kann","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.pcd.2014.05.005_bib0130","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","article-title":"The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients","volume":"26","author":"Riddle","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0135","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc06-1357","article-title":"Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups","volume":"30","author":"Yki-J\u00e4rvinen","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0140","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(08)60485-7","article-title":"Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycemic agents (APOLLO): an open randomised controlled trial","volume":"371","author":"Bretzel","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2014.05.005_bib0145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.28.2.254","article-title":"Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes","volume":"28","author":"Janka","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1532-5415.2007.01043.x","article-title":"Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus","volume":"55","author":"Janka","year":"2007","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.pcd.2014.05.005_bib0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/dc08-0435","article-title":"Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS)","volume":"32","author":"Chan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","article-title":"Comparison of drug adherence rates among patients with seven different medical conditions","volume":"28","author":"Briesacher","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pcd.2014.05.005_bib0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/dc10-1701","article-title":"The DURAbility of Basal versus Lispro mix 75\/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75\/25 and glargine","volume":"34","author":"Buse","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0170","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1464-5491.2005.01511.x","article-title":"Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycemic control in patients with Type 2 diabetes","volume":"22","author":"Malone","year":"2005","journal-title":"Diabet. Med."},{"key":"10.1016\/j.pcd.2014.05.005_bib0175","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"U.K. Prospective Diabetes Study 16: overview of 6 years\u2019 therapy of Type II diabetes: a progressive disease","volume":"44","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2014.05.005_bib0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/17571472.2010.11493315","article-title":"An overview of the healthcare system in Taiwan","volume":"3","author":"Wu","year":"2010","journal-title":"Lond. J. Prim. Care"},{"key":"10.1016\/j.pcd.2014.05.005_bib0185","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.diabet.2007.01.005","article-title":"Insulin therapy for type 2 diabetes: premixed or basal-prandial","volume":"33","author":"Halbron","year":"2007","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.pcd.2014.05.005_bib0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/dmrr.1149","article-title":"Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring","volume":"27","author":"Wang","year":"2011","journal-title":"Diabetes Metab. Res. Rev."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991814000709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991814000709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:54:57Z","timestamp":1761695697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991814000709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1751991814000709"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2014.05.005","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2014.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}